Navigation Links
IDM Pharma Reports 2007 Financial Results

A for L-MTP-PE submitted by the Company may not provide adequate support for regulatory approval of L-MTP-PE in the United States within the timeframe expected by the Company, if at all, whether the Company will be able to manufacture and commercialize L-MTP-PE even if it is approved by regulatory authorities, and whether the cash resources of the Company will be sufficient to fund operations as planned. These and other risks affecting the Company and its drug development programs, intellectual property rights, personnel and business are more fully discussed in the Company's Quarterly Report on Form 10-Q filed with the SEC for the quarter ended September 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.



(in thousands, except per share amounts)


Twelve Months

Quarter Ended December 31, Ended December 31,

2007 2006 2007 2006


Related party

revenue $5,252,000 $2,919,000 $14,246,000 $11,147,000

Research grants and

contract revenue - 28,000 55,000 96,000

License fees,

milestones and

other revenues 299,000 11,000 329,000 43,000

Total revenues 5,551,000 2,958,000 14,630,000 11,286,000

Costs and expenses:

Research and

development 4,796,000 5,297,000 21,828,000 22,329,000

Impairment of

patents and

licenses 416,000 95,000 511,000 592,000

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
(Date:10/9/2015)... Wareham, MA (PRWEB) , ... October 09, 2015 , ... ... for a ventilation solution for their latest project in West Hollywood, CA, they turned ... was the perfect fit for this pristine, Craftsman-style bungalow, and because of our successful ...
(Date:10/9/2015)... ... ... OontZ Angle 3 was featured on NewsWatch as part of its monthly ... Steinberg, a technology expert and special reporter for NewsWatch, conducted the review and shared ... From Cambridge Soundworks is the OontZ Angle 3. This device is a wireless Bluetooth ...
(Date:10/8/2015)... ... 08, 2015 , ... The Clinical Data Interchange Standards Consortium ... a new, patient-centered messaging campaign at its upcoming International Interchange, to be held ... tagline, “Smarter Research to Unlock Cures,” supports numerous healthcare-driven presentations and open panel ...
(Date:10/8/2015)... ... October 08, 2015 , ... ... government agencies, insurers and patients to consistently deliver the highest quality of care, ... technologies in the field. At this year’s NASS meeting, the Spine division of ...
(Date:10/8/2015)... ... October 08, 2015 , ... Three Maricopa ... recent grant announcement made by the U.S. Department of Education. , ... success at the colleges. These grants enable Hispanic Serving Institutions (HSI) to expand ...
Breaking Medicine News(10 mins):
... hope on the horizon for trigeminal neuralgia patients as researchers ... effective way to deal with the pain caused by the ... Wake Forest University Baptist Medical found that the GKRS technique ... 400 patients who underwent the procedure at the center. The ...
... with the outcome of botulinum-a toxin (BTX-A) detrusor ... overactivity. BTX-A detrusor injections have been described in ... spinal cord injury. ,Researchers from Germany ... successfully in children with a neurogenic bladder. After ...
... perhaps for sometime is now confirmed by a survey ... pharmaceutical companies are influencing decisions of doctors about how ... reveals that that the vicious circle is set by ... which drug to prescribe enjoy heavy financial connections and ...
... from two separate trials that Breast cancer patients ... using trastuzumab. //The results of their study were ... of Medicine. The researchers compiled results from two ... with patients receiving both chemotherapy and trastuzumab. Use ...
... currently more than 5.13 million patients are suffering from ... cases being reported each year. Anti-retroviral treatments //have already ... ,The priority of the Indian Government is to ... disease. Inorder to increase awareness and promote community participation, ...
... the first promising news regarding the deadly bird flu virus, ... prototype //of a vaccine developed against the disease was proving ... vaccine against the Asian H5N1 strain of bird flu is ... vaccinate them. If the clinical trials are positive this prototype ...
Cached Medicine News:
(Date:10/8/2015)... CAMBRIDGE, Mass. , Oct. 8, 2015 /PRNewswire/ ... has awarded approximately $40 million to the Broad ... whole genome sequencing of 20,000 individuals, as well ... sequencing and metabolite profiling. Trans-Omics for ... an initial step toward a larger initiative, which ...
(Date:10/8/2015)... , Oct. 08 2015 ... of the "Global API Market Outlook 2020" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Global API Market Outlook 2020" ...
(Date:10/8/2015)... 2015 Hill-Rom Holdings, Inc., (NYSE: HRC ... conference call and webcast from 8:00 a.m. – 9:00 ... 2015. . --> ... will be issued that morning prior to the call ... . .  The webcast slide ...
Breaking Medicine Technology:
... (Nasdaq: DYNT ) today announced results for its fiscal ... income for the quarter ended June 30, 2010, increased 54 percent ... common share) for the quarter ended June 30, 2009. Net income ... $423,977 ($.03 per common share) compared to $103,324 ($.01 per common ...
... HAYWARD, Calif., Sept. 22 Intarcia Therapeutics, Inc. presented ... study of ITCA 650 (DUROS® continuous subcutaneous delivery of ... the 46th Annual Meeting of the European Association for ... (Logo: ) (Logo: ...
Cached Medicine Technology:
Provides stable positioning of a patient during hip surgery. Multi-adjustment arms allow the positioner to be adjusted to fit all sizes of patients. Especially helpful with large patients where reach...
... M3-X Extremity Fixation System is a rigid fixation ... It offers modular instrumentation and a superior ... M3-X features four sizes of true lag ... and foot. OSTEOMED's lag screw design eliminates ...
True/Fix Distal Femoral Nail System...
... the Vortex Vacuum Mixer is clinically proven to ... traditional vacuum mixers. The ergonomically angled base means ... crank three revolutions every time you turn ... stirring, cutting down on the amount of air ...
Medicine Products: